跳至主要内容
临床试验/TCTR20230518002
TCTR20230518002招募中4 期

The study to evaluate the efficacy and safety of using Platelet-rich plasma in treatment of Tear Trough Deformity

ASTRACO MEDICAL NETWORKS LTD.0 个研究点目标入组 30 人开始时间: 2023年5月18日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 Years 至 60 Years(—)
性别
All

入选标准

  • 1. Aged 30-60 years
  • 2. Tear Trough Class I-II by Hirmard's Classification

排除标准

  • 1. Pregnancy or Lactation subjects
  • 2. Subjects with coagulopathy or platelet dysfunction or anemia or cancer or immunocompromised host
  • 3. Current smoking or heavy alcohol drinking subjects
  • 4. Subjects with dermatitis, skin infection at eye
  • 5. Subjects with history of anesthesia allergy
  • 6. Subjects with history of taking contraceptive pills or NSAIDs
  • 7. Subjects who treated with energy-based deviced, laser or botox within 6 month before joining the research
  • 8. Subjects who had history of keloid
  • 9. Subjects who had history of phychiatric disease

研究者

发起方
ASTRACO MEDICAL NETWORKS LTD.

相似试验